Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer

被引：0
|
作者：
Ylstra, B. [1 ]
Cordes, M. [1 ]
Biesma, H. D. [1 ]
Verheul, H. M. [2 ]
Neerincx, M. [2 ]
Koopman, M. [3 ]
Punt, C. J. [4 ]
Meijers, G. A. [5 ]
Murphy, V. [6 ]
Barat, A. [7 ]
Betge, J. [8 ]
Ebert, M. [8 ]
Gaiser, T. [8 ]
Fender, B. [9 ]
Klinger, R. [10 ]
Das, S. [7 ]
Smeets, D. [11 ]
Lambrechts, D. [11 ]
Byrne, A. T. [7 ]
Van Grieken, N. C. T. [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Pathol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Oncol, Amsterdam, Netherlands
[3] Univ Med Ctr Utrecht, Dept Oncol, Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Oncol, Amsterdam, Netherlands
[5] Antoni van Leeuwenhoek, Het Nederlands Kanker Inst, NKI AVL, Dept Pathol, Amsterdam, Netherlands
[6] ICORG, Dept Clin Res, Dublin, Ireland
[7] RCSI, Dept Physiol & Med Phys, Dublin, Ireland
[8] Univ Klinikum Mannheim, Dept Med 2, Mannheim, Germany
[9] OncoMark Ltd, Dept Res & Dev, Dublin, Ireland
[10] Univ Coll Dublin, Conway Inst, Dublin, Ireland
[11] KU Leuven VIB, Vesalius Res Ctr, Leuven, Belgium
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷
关键词：
D O I：
10.1016/S0959-8049(16)32666-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
66
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [31] TIE2-expressing myeloid cells as a predictive marker for bevacizumab-containing chemotherapy in metastatic colorectal cancer.
    Matsusaka, S.
    Suenaga, M.
    Mishima, Y.
    Takagi, K.
    Shinozaki, E.
    Terui, Y.
    Mizunuma, N.
    Hatake, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer
    Zuurbier, Linda
    Rahman, Arman
    Cordes, Martijn
    Scheick, Jennifer
    Wong, Tse J.
    Rustenburg, Francois
    Joseph, Jesu Christopher
    Dynoodt, Peter
    Casey, Rory
    Drillenburg, Paul
    Gerhards, Michael
    Barat, Ana
    Klinger, Rut
    Fender, Bozena
    O'Connor, Darran P.
    Betge, Johannes
    Ebert, Matthias P.
    Gaiser, Timo
    Prehn, Jochen H. M.
    Griffioen, Arjan W.
    van Grieken, Nicole C. T.
    Ylstra, Bauke
    Byrne, Annette T.
    van der Flier, Laurens G.
    Gallagher, William M.
    Postel, Ruben
    ONCOTARGET, 2017, 8 (26) : 42949 - 42961
  • [33] Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer
    Gampenrieder, S. P.
    Hufnagl, C.
    Brechelmacher, S.
    Huemer, F.
    Hackl, H.
    Rinnerthaler, G.
    Romeder, F.
    Fuentes, C. Monzo
    Morre, P.
    Hauser-Kronberger, C.
    Mlineritsch, B.
    Greil, R.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (04): : 344 - 350
  • [34] Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer
    Gampenrieder, S. P.
    Hufnagl, C.
    Brechelmacher, S.
    Huemer, F.
    Hackl, H.
    Rinnerthaler, G.
    Romeder, F.
    Muss, C.
    Pircher, M.
    Ressler, S.
    Kronberger, C.
    Mlineritsch, B.
    Greil, R.
    CANCER RESEARCH, 2013, 73
  • [35] Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer
    S P Gampenrieder
    C Hufnagl
    S Brechelmacher
    F Huemer
    H Hackl
    G Rinnerthaler
    F Romeder
    C Monzo Fuentes
    P Morre
    C Hauser-Kronberger
    B Mlineritsch
    R Greil
    The Pharmacogenomics Journal, 2017, 17 : 344 - 350
  • [36] Bevacizumab associated calcifications might be a prognostic marker in patients with metastatic colorectal cancer.
    Zhou, Yuwen
    Meng, Qiu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
    Shih-Hsin Chen
    Julien Edeline
    Kai-Keen Shiu
    Sarah Benafif
    Sofia Wong
    Ashley Groves
    John Bridgewater
    Balaji Ganeshan
    Cancer Imaging, 15 (Suppl 1)
  • [38] Allelic loss of 18q21.1 (D18s474) as independent prognostic marker in colorectal cancer
    Rosler, Eduard
    Reiter, Contantin
    Kudlich, Theodor
    Luehrs, Hardi
    Illert, Betram
    Katzenberger, Tiemo
    Gostner, Andrea
    Scheurlen, Michael
    Scheppach, Wolfgang M.
    Melcher, Ralph
    GASTROENTEROLOGY, 2007, 132 (04) : A620 - A620
  • [39] Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database
    Margalit, Ofer
    Harmsen, William S.
    Shacham-Shmueli, Einat
    Voss, Molly M.
    Boursi, Ben
    Wagner, Anna D.
    Cohen, Romain
    Olswold, Curtis L.
    Saltz, Leonard B.
    Goldstein, Daniel A.
    Hurwitz, Herbert
    Tebbutt, Niall C.
    Kabbinavar, Fairooz F.
    Adams, Richard A.
    Chibaudel, Benoist
    Grothey, Axel
    Yoshino, Takayuki
    Zalcberg, John
    de Gramont, Aimery
    Shi, Qian
    Lenz, Heinz-Josef
    EUROPEAN JOURNAL OF CANCER, 2023, 178 : 162 - 170
  • [40] Lower frequency of allele loss on chromosome 18q in human breast cancer than in colorectal tumors
    Schenk, M
    LeibMosch, C
    Schenck, IU
    Jaenicke, M
    Indraccolo, S
    Saeger, HD
    DallenbachHellweg, G
    Hehlmann, R
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1996, 74 (03): : 155 - 159
12345